Germany’s Evonik starts to build methionine unit in Singapore

02 August 2012 10:44  [Source: ICIS news]

SINGAPORE (ICIS)--Germany’s Evonik has started construction of a 150,000 tonne/year methionine complex on Jurong Island, Singapore, that is scheduled to start operations in the third quarter of 2014, the specialty chemicals major said on Thursday.   

Evonik is spending more than €500m ($610m), its biggest single investment to date, on building the complex, the company said in a statement.

“We opted for Asia as the site for this plant because it is the fastest growing methionine market in the world,” said Klaus Engel, CEO of Evonik.

The company currently has four plants across Germany, Belgium and the US, and will have the capacity to produce 580,000 tonnes/year of methionine once the unit in Singapore starts production in 2014.

“The manufacturing complex in Singapore will complement our global positioning, meaning we will henceforth be represented in all the key market regions,” said Reiner Beste, head of Evonik’s Health & Nutrition Business unit.  

($1 = €0.82)

By: Joey Lau

AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly